 |
 |
Location:
Hilton San Diego Bayfront ∙ San Diego, CA
Date:
Wednesday, May 6, 2020
Time:
6:30 – 7:00PM - Registration with Cocktail Reception
7:00 – 9:00PM - Educational Program
Activity Description
Atrial Fibrillation (AF) and other Supraventricular Tachycardias (SVTs) continually present a burden on the healthcare system. This is in large part due to inadequacies in current standard of care practices including diagnosis, treatment, and monitoring. It is therefore necessary to pursue, evaluate and adopt emergent solutions and technologies that may provide salient paradigm shifts in current therapeutic approaches.
This educational symposium has been designed to examine innovative diagnostic, treatment, and monitoring options for atrial fibrillation and other supraventricular tachycardias. First, the expert faculty will discuss advances in the utility of wearable devices in “above the ventricle” arrhythmia diagnosis and/or monitoring. The benefits and challenges of current treatment modalities for acute episodes of AF and other SVTs, as well novel approaches in development for the acute termination of SVT episodes will be explored. Next, emergent approaches for acute management of intermittent AF will be examined. Finally, the targeting of novel channels for AF termination will be discussed.
Agenda
| Agenda |
||
| 6:30 – 7:00PM | Registration with Cocktail Reception, followed by Dinner Seating | |
| 7:00 – 7:15PM | Welcome and Introductions Paul Dorian, MD |
|
| 7:15 – 7:30PM | State of the Art in Mobile AF/SVT Diagnosis and Monitoring Mintu Turakhia, MD, MAS |
|
| 7:30 – 7:45PM | The Evolution of Acute Treatment for Atrial Fibrillation and other Prevalent SVTs John Camm, MD |
|
| 7:45 – 8:00PM | A Novel Calcium Channel Blocker for Acute Treatment of PSVT Episodes Bruce Stambler, MD |
|
| 8:00 – 8:15PM | Inhaled Flecainide for Conversion of Recent Onset AF John Camm, MD |
|
| 8:15 – 8:30PM | SK Channel Inhibition for the Treatment of Atrial Fibrillation Peter Kowey, MD |
|
| 8:30 – 9:00PM | Panel Discussion with Attendee Q&A Moderator: Paul Dorian, MD Panel: Mintu Turakhia, MD, MAS, Bruce Stambler, MD, John Camm, MD, Peter Kowey, MD |
Commercial Support
This activity is supported through educational grants from:
Milestone Pharmaceuticals USA, Inc., Acesion Pharma ApS, and InCarda Therapeutics, Inc.
Joint Providership
MediaSphere Medical, LLC and Ciné-Med
Faculty
Program Direcor
Paul Dorian, MD
Professor of Medicine, University of Toronto
Division of Cardiology, St Michael’s Hospital
Toronto, ON, Canada
Faculty
John Camm, MD
Professor of Clinical Cardiology
St George’s University of London
London, UK
Peter Kowey, MD
Chief of the Division of Cardiovascular Diseases, Main Line Health System, Wynnewood, PA
Emeritus Chief of Cardiology of the Lankenau Heart Institute
Professor of Medicine and Clinical Pharmacology, Jefferson Medical College
Philadelphia, PA
Bruce Stambler, MD
Piedmont Heart Institute
Atlanta, GA
Mintu Turakhia, MD, MAS
Executive Director, Center for Digital Health, Stanford University
Director of Cardiac Electrophysiology, VA Palo Alto Health Care System
Palo Alto, CA
CME Accreditation
Target Audience
This educational program has been developed to meet the educational needs of electrophysiologists, cardiologists and other physicians and associated professionals who are dedicated to the management of patients with Atrial Fibrillation and other prevalent supraventricular arrhythmias.
Learning Objectives
Upon completion of this educational activity, participants will be able to:
- Review current state and future directions of wearable devices as diagnostic and monitoring tools in AF and other SVTs.
- Review current treatment options for acute episodes of AF and other SVTs, including benefits and challenges.
- Explore novel approaches for the acute treatment of PSVT.
- Evaluate novel approaches for acute management of intermittent AF.
- Examine advances in therapeutic inhibition of novel ion channels for AF management.
Activity Goal
This activity is designed to address the following ABMS/IOM competencies: Patient Care, Medical Knowledge, and Practice-Based Learning.
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by MediaSphere Medical and Ciné-Med. Ciné-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Ciné-Med designates this educational activity for a maximum of 2 AMA PRA CATEGORY 1 Credit(s)TM.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
Ciné-Med designates this activity for 2 Contact Hours for nurses.
Disclosure Policy
MediaSphere Medical and Ciné-Med adheres to accreditation requirements regarding industry support of continuing medical education. Disclosure of the planning committee and faculty’s commercial relationships will be made known at the activity on course hand-outs and during faculty presentations. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations.
All MediaSphere Medical and Ciné-Med employees in control of content have indicated that they have no relevant financial relationships to disclose.
It is the policy of MediaSphere Medical and Ciné-Med to ensure balance, independent objectivity, and scientific rigor in all its supported educational programs. All faculty members participating in educational activities are required to disclose to the program audience any real of apparent conflicts of interest held within the past 12 months.
MediaSphere Medical and Ciné-Med implement a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
Non-Endorsement Statement
MediaSphere Medical and Ciné-Med verifies that sound education principles have been demonstrated in the development of this educational offering as evidenced by the review of its objectives, teaching plan, faculty, and activity evaluation process. MediaSphere Medical and Ciné-Med does not endorse or support the actual opinions or material content as presented by the speaker(s) and/or sponsoring organization.